Ribonuclease inhibitor and angiogenin system regulates cell type-specific global translation.

Stillinovic, Martina; Sarangdhar, Mayuresh Anant; Andina, Nicola; Tardivel, Aubry; Greub, Frédéric; Bombaci, Giuseppe; Ansermet, Camille; Zatti, Marco et al. · Sci Adv · 2024

basic_science · Level V

Where this comes from

Abstract

Translation of mRNAs is a fundamental process that occurs in all cell types of multicellular organisms. Conventionally, it has been considered a default step in gene expression, lacking specific regulation. However, recent studies have documented that certain mRNAs exhibit cell type-specific translation. Despite this, it remains unclear whether global translation is controlled in a cell type-specific manner. By using human cell lines and mouse models, we found that deletion of the ribosome-associated protein ribonuclease inhibitor 1 (RNH1) decreases global translation selectively in hematopoietic-origin cells but not in the non-hematopoietic-origin cells. RNH1-mediated cell type-specific translation is mechanistically linked to angiogenin-induced ribosomal biogenesis. Collectively, this study unravels the existence of cell type-specific global translation regulators and highlights the complex translation regulation in vertebrates.

Medical subject headings